Venture Capital News Daily
   Your Source for Venture Capital and Private Equity Financings
   Massinvestor/VC News Daily      
   Venture Capital News Daily on RSS Venture Capital News Daily on Facebook Venture Capital News Daily on Twitter
VC Directories Mobile Apps Celebrity VCs VentureTrackr Archive About Us
 
VC-funded Company:


Xeris Pharmaceuticals
3208 Red River Street, Suite 300
Austin, TX 78705
Phone: 512-498-2670
http://xerispharma.com/

Xeris is an Austin, Texas-based, specialty biopharmaceutical company developing improved and differentiated injectable therapeutics for multiple indications including diabetes. The company's proprietary XeriSol(TM) and XeriJect(TM) formulation technologies allow for the subcutaneous and intradermal delivery of highly concentrated, non-aqueous, ready-to-inject formulations of peptides, proteins, antibodies and small molecules using auto-injectors, multi-dose pens and pumps. Xeris' proprietary formulation platforms have the potential to offer distinct advantages over existing products and formulations including: up to 1000-fold lower injection volumes, long term room-temperature stability, elimination of reconstitution and refrigeration, all of which can lead to products that are easier to use by patients, caregivers, health practitioners, and can reduce costs for payers and the healthcare system.

Key Contact
NameTitleE-Mail
Paul R. EdickCEOpedick@xerispharma.com


Funding Events
DateAmountTypeInvestors
05/19/17$30,000,000 Merieux Developpement
 
Massinvestor/VC News Daily
617-620-4606


© 2017 Massinvestor, Inc.